Anavex Life Sciences Corp (AVXL)

[ignatiusrielly35]

“When trials take so long to readout it is an indication IMHO that a level of creativity is required to present what is likely good or even great signals, while navigating a potential way to optimise for possible early approvals.”

That is a negative assumption on your part. You don’t know since you are not an insider. The explanations from the company you choose not to believe. Every readout has been delayed, yet, for example, the EMA obviously liked the full AD results. Which still have not been fully reported. Hence, there must be a different reason for that fact other than sugarcoating mediocre results, as you suggest.